Skip Nav Destination
Strategic Pricing of New Pharmaceuticals
The Review of Economics and Statistics (1998) 80 (1): 108–118.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Kurt R. Brekke
- Dag Morten Dalen
- Odd Rune Straume
Journal of Health Economics (2025) 101: 102976.
- Aniek Dane
- Carin Uyl-de Groot
- Hugo van der Kuy
Frontiers in Pharmacology (2024) 15
- Anna Scedrova
- Robert E. Morgan
- Luigi M. De Luca
European Management Journal (2024) 42 (5): 813.
- Jennifer Kao
Management Science (2024)
- Josh Feng
- Luca Maini
Management Science (2024) 70 (12): 8940.
- Leandro Meller
- Juan Marcelo Virdis
- Emiliano Gutiérrez
- Diego Leandro Domínguez
Revista de Métodos Cuantitativos para la Economía y la Empresa (2024) 38: 1.
- Kurt R. Brekke
- Dag Morten Dalen
- Odd Rune Straume
Journal of Health Economics (2023) 90: 102778.
- Ram Kumar Dhurkari
Journal of Revenue and Pricing Management (2023) 22 (1): 85.
- Mikel Berdud
- Niklas Wallin-Bernhardsson
- Bernarda Zamora
- Peter Lindgren
- Adrian Towse
Value in Health (2023) 26 (3): 328.
- H. E. Frech
- Mark V. Pauly
- William S. Comanor
- Joseph R. Martinez
Journal of Benefit-Cost Analysis (2022) 13 (2): 166.
- Frank R. Lichtenberg
Journal of Evolutionary Economics (2022) 32 (4): 1155.
- James M. Plečnik
- Leo L. Yang
- Joseph H. Zhang
Accounting & Finance (2022) 62 (S1): 2011.
- Netra Singh
- Aradhana Sorout
Industrija (2022) 50 (3-4): 7.
- Jennifer L. Kao
SSRN Electronic Journal (2022)
- Kurt R. Brekke
- Dag Morten Dalen
- Odd Rune Straume
Journal of Health Economics (2022) 83: 102613.
- David Granlund
Review of Industrial Organization (2022) 60 (1): 63.
- Alice M. Ellyson
- Anirban Basu
Health Economics (2021) 30 (5): 1070.
- Frank R. Lichtenberg
Health Economics (2021) 30 (8): 1910.
- Mark V. Pauly
- William S. Comanor
- H.E. Frech
- Joseph R. Martinez
Value in Health (2021) 24 (10): 1476.
- Kathleen Iacocca
- Beth Vallen
Journal of Public Policy & Marketing (2021) 40 (4): 538.
- Sean Dickson
JAMA Network Open (2020) 3 (9): e2016388.
When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing
- Fanor Balderrama
- Lisa J. Schwartz
- Christopher J. Longo
Health Care Analysis (2020) 28 (2): 121.
- Sabrina Terrizzi
- Chad Meyerhoefer
Contemporary Economic Policy (2020) 38 (1): 94.
- Son Le
- Neel U. Sukhatme
International Review of Law and Economics (2020) 64: 105934.
- Simona Gamba
- Paolo Pertile
- Sabine Vogler
Health Economics (2020) 29 (S1): 47.
- Kozo Ueda
- Kota Watanabe
- Tsutomu Watanabe
American Economic Journal: Macroeconomics (2019) 11 (2): 310.
- Alexander Roediger
- Tim Wilsdon
- Artes Haderi
- Kathy Pendleton
- Boris Azais
Health Policy (2019) 123 (7): 652.
- Derek J Ward
- Lucy Doos
- Andrew Stevens
BMJ Open (2019) 9 (5): e027625.
- Carolin Mauch
- Jens Robert Schöndube
European Accounting Review (2019) 28 (1): 151.
- Sean Dickson
- Ian Reynolds
JAMA Network Open (2019) 2 (7): e196541.
- Michael L. Lanthier
- Kirk W. Kerr
- Kathleen L. Miller
Clinical Pharmacology & Therapeutics (2019) 106 (5): 1125.
- Maria Angelica Borges dos Santos
- Leticia Lucia dos Santos Dias
- Cláudia Du Bocage Santos Pinto
- Rondineli Mendes da Silva
- Claudia Garcia Serpa Osorio-de-Castro
Journal of Pharmaceutical Policy and Practice (2019) 12 (1)
- Ameet Sarpatwari
- Jonathan DiBello
- Marie Zakarian
- Mehdi Najafzadeh
- Aaron S. Kesselheim
- Joel Lexchin
PLOS Medicine (2019) 16 (7): e1002872.
- Margaret K. Kyle
Review of Industrial Organization (2018) 53 (1): 211.
- William S. Comanor
- Stuart O. Schweitzer
- Jon M. Riddle
- Frederic Schoenberg
Review of Industrial Organization (2018) 52 (4): 589.
- Weiwei Chen
- Mark Messonnier
- Fangjun Zhou
Health Economics (2018) 27 (2): 252.
- Jörg Mahlich
- Isao Kamae
- Rosarin Sruamsiri
Expert Review of Pharmacoeconomics & Outcomes Research (2018) 18 (3): 339.
- Mingyue Zhao
- Jing Wu
Expert Review of Pharmacoeconomics & Outcomes Research (2017) 17 (3): 311.
- David B. Ridley
- Su Zhang
International Journal of Industrial Organization (2017) 50: 186.
- Guneet Kaur Nagpal
- Deepak Jena
- Atul A. Nerkar
- Rajdeep Grewal
SSRN Electronic Journal (2017)
- G. Caleb Alexander
- Jeromie Ballreich
- Mariana P. Socal
- Taruja Karmarkar
- Antonio Trujillo
- Jeremy Greene
- Joshua Sharfstein
- Gerard Anderson
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2017) 37 (11): 1469.
- Daniel S. Hosken
- Luke M. Olson
- Loren K. Smith
Economic Inquiry (2016) 54 (1): 342.
- Geoffrey F. Joyce
- Neeraj Sood
Journal of Policy Analysis and Management (2016) 35 (4): 970.
- JA DiMasi
- R Chakravarthy
Clinical Pharmacology & Therapeutics (2016) 100 (6): 754.
- Yu-Hung Chen
- Baojun Jiang
SSRN Electronic Journal (2016)
- David H. Howard
- Peter B. Bach
- Ernst R. Berndt
- Rena M. Conti
Journal of Economic Perspectives (2015) 29 (1): 139.
- Sara Parker-Lue
- Michael Santoro
- Greg Koski
Annual Review of Pharmacology and Toxicology (2015) 55 (1): 191.
- Ali Shajarizadeh
- Aidan Hollis
Health Economics (2015) 24 (8): 966.
- Kathleen Iacocca
- James Sawhill
- Yao Zhao
International Journal of Pharmaceutical and Healthcare Marketing (2015) 9 (1): 3.
- Michele Pistallato
SSRN Electronic Journal (2015)